Hepatitis C Virus in Patients with Cryoglobulinemia Type II by Pascual, Manuel et al.
110 1990;162 (August) Correspondence 569
washing and wearing gowns and gloves are important infection con-
trol measures, whereas the aerosol dissemination of influenza virus
necessitates masks to prevent spread. A large prospective study using
viral cultures as well as serology is needed to assess more accurately
the scope of this problem in older persons.
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Hepatitis C Virus in Patients with
Cryoglobulinemia Type II
COLLEAGUES-The association between cryoglobulinemia and hep-
atitis B virus (HBV) infection has been described [1]. Cryoglobulins
have been found in 6%-43 % ofpatients with chronic liver diseases,
whether or not the liver disease was due to HBV [2]. Such cryoglobu-
lins are most often of the mixed type without a monoclonal compo-
nent [3]. This association is even stronger when the analysis is
reversed: Two-thirds of patients with mixed essential cryoglobulin-
emia have a liver disease or abnormalities in liver function tests [1,
2]. Type IT cryoglobulinemia is characterized by the presence in the
cryoprecipitate of a monoclonal immunoglobulin that binds t9 Fc
portions of polyclonal IgG; most often this monoclonal component
is an IgMK. Ofthose with this type ofcryoglobulinemia, >50% have
some liver disease, including cryptogenic chronic hepatitis or HBV
~hronic hepatitis [1, 2]. Although this high incidence has not been
found everywhere [1], the association between chronic liver disease
and cryoglobulins of type IT is unlikely to be fortuitous.
Serologic markers for HBV and hepatitis C virus (HCV) antibod-
ies [4] were measured in 10 patients with cryoglobulinemia type' IT
(all: IgMK/polyclonal IgG). Six patients had positive markers for
hepatitis B, and three had HCV antibodies detected by enzyme-linked
immunosorbent assay (Ortho HCV ELISA; Ortho Pharmaceutical,
Raritan, NJ; optical density at 490 om: 1.7, 1.02, and >2 for a cutoff
of 0.45.
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Only 1 of3 patients with antibodies to HCV had hepatitis B mark-
ers: a 33-year-old man with a history ofdrug addiction. He had an-
tibodies to hepatitis B surface antigen (HBsAg) but was negative for
HBsAg. He had moderately elevated transaminases, and liver bi-
opsy showed chronic fibrosing hepatitis with a negative stain for hep-
atitis B core antigen by immunofluorescence. The most likely
diagnosis was chronic HCV hepatitis [5].
The second patient, a 44-year-old man, had membranoprolifera-
tive glomerulonephritis, which was treated successfully with steroids
and cyclophosphamide, and persistently elevated transaminase lev-
els of 4 years duration. He declined liver biopsy. The last patient
was 68 years old and, except for purpura, had no complaints. Liver
function tests showed a slight increase in -y-glutamyltransferase (59
units/I; normal, <42 units/I) and alkaline phosphatase (131 units/I;
normal, <125 units/I); however, transaminases were normal.
Although the number of patients is small, our observation sug-
. gests an association between HCV and cryoglobulinemia type II.
The emergence of a monoclonal rheumatoid factor has been linked
to chronic viral infection (Epstein-Barr virus [6], HBV [1]), which
might participate in the activation process leading to the uncontrolled
proliferation of a B cell clone. Hepatitis C virus may have a similar
effect.
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Campylobacter jejuni versus Campylobacter coli in
Developing Countries: How Accurate Are
Prevalence &timates?
COLLEAGUES - Campylobacter species are an important cause of in-
fectious diarrhea, especially endemic diarrhea among children of
developing countries and adults traveling to these areas. Because
Campylobacter coli is generally thought to occur in <5 % of human
Campylobacter infections, most clinical laboratories do not attempt
to distinguish between C. coli and Campylobacter jejuni [1]. Un-
speciated Campylobacter isolates from diarrhea surveys are com-
monly reported as "Campylobacter spp.,""C. jejuni/coli," or simply
"Co jejuni." As a result, the frequency of C. coli infections and its
relative importance as a diarrheal agent are unknown for many areas
of the world.
During 1984-1989, 513 diarrheic and 379 nondiarrheic stool spec-
imens from adult US citizens living in or visiting Lima, Peru, were
tested for presence of Campylobacter and other common bacterial
enteropathogens. On the whole, Campylobacter organisms were a
less important cause ofdiarrhea than anticipated, being isolated from
6.1%of cases and 2.1%of controls, accounting for only 17%of all
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enteropathogens isolated from patients with diarrhea. Campylobac-
ter isolates were speciated according to their ability to hydrolyze
hippurate [1). The isolation frequency for C. jejuni was 2.5% from
stools ofdiarrheic individuals and 1.3%from control stools. C. coli,
however, was less frequently isolated from cases (0.8 %) than from
controls (1.6%), suggesting C jejuni may be the only important cause
of Campylobacter-associated diarrhea in adult travelers to Peru. Fur-
thermore, because 36% of Campylobacter isolates were C. coli, the
true frequency of C. jejuni-associated diarrhea could have been over-
estimated by 144% if it had been assumed that most isolates were
C. jejuni.
These limited results indicate American adults living in or traveling
to Peru are at relatively low risk of developing Campylobacter-
associated diarrhea. Not surprisingly, most of the risk is attributable
to C. jejuni. However, the high proportion of C. coli isolates among
all Campylobacter species isolated suggests that infection or tran-
sient colonization by this organism may be much more common in
many areas of the world than previously considered. For Peru and
other countries where C. coli is prevalent, the unexpectedly high
proportion of C. coli among all Campylobacter isolates could lead
to inflated estimates of the relative importance of C. jejuni if each
species is not considered separately. To establish whether this
phenomenon occurs in other geographic regions, we encourage di-
arrheal disease investigators to report Campylobacter isolates ac-
cording to species.
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